Introduction
In Type-1 diabetes mellitus (T1DM), insulin-producing beta cells of the pancreatic islets (PIs) are progressively destroyed, and insulin production is reduced, resulting in an extremely low level of the plasma insulin. [1] [2] [3] Exogenous insulin injection has prolonged the survival of diabetic patients and has prevented systemic complications. Moreover, the tight control of glycemia by insulin and body weight has further improved survival and reduced complications. 4 However, the quality of life of diabetic patients is significantly impaired by the requirement for a strict diet and multiple injections of insulin, and the tight control of glucose homeostasis with insulin injection therapy is very difficult owing to the induction of hypoglycemia. 5 Therefore, the transplantation of isolated PIs constitutes a more physiological therapy than exogenous insulin injection, as transplanted PIs work functionally as a regulator of blood glucose. 6, 7 PI-grafts via the portal vein (PV) are more efficient in normalizing glucose metabolism and result in longer survival rates than systemically draining (such as by renal subcapsular or subcutaneous transplantation) PI-grafts. [8] [9] [10] [11] [12] Although immunosuppressive agents and techniques for the isolation of a large number of functional PIs have made PI-transplantation a possible therapeutic approach for the treatment of diabetic patients, rejection owing to strong antigenicity of PIs remains a major cause preventing widespread clinical application in spite of the usage of immunosuppressants. 12 Moreover, side effects from the continuous use of immunosuppressants have been reported, including the development of malignancies, opportunistic infections and organ toxicity. In this respect, tolerance induction by hematopoietic chimerism is superior to nonspecific immunosuppression.
reported the induction of donor-specific tolerance by bone marrow chimerism to eliminate the problem of allograft rejection. [14] [15] [16] We have developed more effective bone marrow transplantation (BMT) methods for the induction of acceptance of donor bone marrow cells (BMCs) than conventional intravenous injection of BMCs (IV-BMT); one method is BMC-transplantation into the liver via the PV (PV-BMT) and the other is intra-bone marrow (IBM)-BMT. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Based on our findings, we have developed a strategy to permit the long-term acceptance of allogeneic PIs by intra-hepatic transplantation of PIs plus whole-donor BMCs, followed by IV injection of whole BMCs on day 5 after PItransplantation without immunosuppressants in rats. 20 Although irradiation doses as pre-conditioning can be reduced in comparison with IV-administration of BMCs (IV-BMT), additional IV injection of BMCs is necessary in this method. For clinical application of PI-transplantation and BMT from brain-dead patients to patients with T1DM, the transplantation of organ grafts and BMT should be carried out on the same day. Therefore, a single-day protocol needed to be established. 21 In the present study, we compare PV-BMT and IBM-BMT in terms of the acceptance of donor PIs, and show that PV-BMT þ IBM-BMT is an effective new method.
Materials and methods

Animals
Eight-to 10-week-old male Brown Norway (BN, RT1A n , RT1B n ) and 7-to 9-week-old female Fischer 344 (F344,  RT1A l , RT1B l ) rats were purchased from Clea Japan Inc. (Tokyo, Japan) as donors and recipients, respectively, and maintained in our conventional animal facilities. ACI (August Copenhagen Irish, RT1A a , RT1B a ) rats were also obtained from Clea Japan.
Pharmacologic induction of diabetes
Diabetes mellitus was induced in normal F344 rats by a single i.p. injection of 70 mg/kg of STZ (Nacalai Tesque, Osaka, Japan), which is directly toxic to beta cells and induces an outbreak of clinical diabetes within 3 days. 22 Diabetic F344 rats showing more than 400 mg/dl for at least 3 consecutive days in non-fasting plasma glucose were used as recipients.
Transplantation
Diabetic F344 rats were irradiated (8, 8.5 or 9 Gy) with a single dose from a 137 Cs source 1 day before transplantation (day -1). On day 0, PI-transplantation and BMT were performed almost simultaneously. PIs were isolated by the collagenase technique, and PI-transplantation was performed as described previously. 20, 23 Under pentobarbital (Essex Animal Health Friesoythe, Friesoythe, Germany) anesthesia, the peritoneal cavity of the recipient was accessed through a midline incision. The 600 PIs from BN rats were transplanted into the liver via the PV using a 26-gauge needle. After infusion, the syringe was rinsed several times by repeated aspiration and reinfusion of PV blood. BMCs were collected from the femurs and tibias of BN rats, and 3 Â 10 8 whole BMCs were injected into the recipients. The routes of injection of the BMCs were (i) intra-vein (IV), (ii) intra-PV, (iii) IBM or (iv) PV þ IBM. The IV injections of BMCs were given via the lateral tail vein. When we performed IBM-BMT, phosphate-buffered saline containing donor BMCs was adjusted to 0.2 ml per rat. The knees of the recipients were flexed to 901, and the donor BMCs were injected into the bone marrow cavity through the joint surface of the tibia from the patellar tendon using a 26-gauge needle. When we used the PV þ IBM route, we divided the BMCs equally and 1.5 Â 10 8 BMCs were injected into the PV and IBM, respectively. Thus, several experimental groups were set up: (1) 9 Gy irradiation plus IV-BMT(9 Gy þ IV), (2) 8.5 Gy irradiation plus IV-BMT (8.5 Gy þ IV), (3) 9 Gy irradiation plus PV-BMCs (9 Gy þ PV), (4) 8.5 Gy irradiation plus PV-BMT (8.5 Gy þ PV), (5) 9 Gy irradiation plus IBM-BMT (9Gy þ IBM), (6) 8.5 Gy irradiation plus IBM-
PIs were injected into the liver via the PV in all groups.
Criteria for rejection
Graft rejection was considered to have occurred when posttransplantation non-fasting plasma glucose levels exceeded 300 mg/dl for two consecutive measurements.
Flow cytometric analyses
Major histocompatibility complex (MHC) class I (RT1A l or RT1A n ) surface markers were examined for peripheral blood mononuclear cells (PBMCs) of recipients by a FACScan (Becton Dickinson, Mountain View, CA, USA). Briefly, peripheral blood (PB) was layered over lymphocyte separation medium (Lympholyte-Mammal, Cedarlane Laboratories Ltd, Hornby, Ontario, Canada) and centrifuged at 181C (5000 r.p.m. for 30 min). The mononuclear cell layer was aspirated from the serumlymphocyte separation medium interface and washed. Cells were stained with fluorescein isothiocyanatelabeled anti-RT1A l monoclonal antibodies (mAbs) against recipient MHC class I (RT1A l PharMingen, San Diego, CA, USA), and mAbs against donor MHC class I (RT1A n Serotec, Oxford, England), followed by staining with phycoerythrin-labeled anti-mouse immunoglobulinG antibodies (Abs) (Serotec).
Glucose tolerance tests
Five months after the PI transplantation, glucose tolerance tests (GTTs) were performed. Food was removed for 16 h before the GTTs. The rats were injected IV with 2 mg of glucose per gram of body weight. Blood samples were obtained 15, 30, 60 and 120 min after the glucose injection. Plasma glucose levels were analyzed by a glucose oxidase method.
Measurement of serum insulin levels
Food was removed for 16 h before the measurement of serum insulin levels. Rats were injected IV with 2 mg of glucose per gram of body weight. Blood samples were obtained at 30 min after glucose injection and measured for serum insulin levels using an enzyme-linked immunosorbent assay method. 23 
Histological findings
The livers of the recipient rats were removed and fixed in 10% buffered formalin, and stained with hematoxylin and eosin (H-E), and with anti-insulin, anti-glucagon and somatostatin Abs (DAKO, Glostrup, Denmark) to identify the grafted PIs.
Mixed lymphocyte reaction
For mixed lymphocyte reaction (MLR), splenic T cells were obtained by passing spleen cells through a nylon-wool fiber (Wako Pure Chemical, Osaka, Japan) column after incubation for 60 min at 371C; 1 g of the nylon-wool fiber was prepared for 3 Â 10 6 splenocytes as responders. The T lymphocytes (3 Â 10 5 ) were cocultured with 20 Gy-irradiated whole spleen cells (3 Â 10 5 : stimulator cells) from F344, BN or ACI in a total of 200 ml of Rosewell Park Memorial Institute 1640 medium supplemented with 10% heat-inactivated fetal bovine serum, and 50 mM of 2-mercaptoethanol (Wako). The cells were incubated at 371C for 5 days in a humidified 5% CO 2 environment in 96-well flat-bottom microwell trays (Corning Glass Works, Corning, NY, USA), and pulsed with 0.5 mCi [ 3 H]-thymidine per well for the last 20 h of the culture period. Stimulation indices were calculated by normalization to self-reactivity, which was near background incorporation in all cases.
Statistical analyses
Statistical analyses were performed using a two-tailed Student's t-test, except for graft survival rates. Statistical analyses of graft survival rates were performed using a logrank test. Simultaneously, BMCs of BN were transplanted into vein, BM, PV or PV þ BM, as described in the 'Materials and methods'. Graft rejection was considered to have occurred when post-transplantation non-fasting plasma glucose levels exceeded 300 mg/dl for two consecutive measurements. Although we monitored the results until 250 days after simultaneous transplantation of BMCs and PIs, rejection occurred within 200 days after transplantation. Therefore, in this figure, we show the graft survival terms of individual rats in the experimental groups until 200 days after transplantation.
Results
Graft survival
First, we compared the effect of IV-BMT, PV-BMT and IBM-BMT on the acceptance of allogeneic transplantation of PIs. As shown in Figure 1 , plasma glucose levels in all recipient rats returned to normal levels within 24 h after the transplantation of PIs and BMCs. In the '9 Gy þ IV' and '8.5 Gy þ IV' groups, the transplanted PIs in the recipient rats were rejected within 85 days and 25 days, respectively (Figures 1 and 2) . The '9 Gy þ PV' group showed a 70% graft survival rate at 250 days after the transplantation, whereas most of the transplanted PIs in the '8.5 Gy þ PV' group were rejected within 50 days after transplantation, and only one rat showed normal glycemia at 50 days after transplantation, but the graft was rejected at 185 days. The '9 Gy þ IBM' group showed a 100% graft survival rate at 250 days after the transplantation. In the 'IBM-BMT' groups, graft survival rates at 250 days for 8.5 and 8 Gy irradiation were 44.4% (4/9) and 20% (2/10), respectively. Therefore, we confirmed that PV-BMT is more effective in inducing the acceptance of allogeneic PIs than IV-BMT, as described previously, 20 and that IBM-BMT is more effective in inducing the acceptance of allogeneic PIs than PV-BMT. Next, we examined the effect of the combination of PV-BMT þ IBM-BMT ('PV þ IBM'-BMT). We divided the BMCs equally and transplanted each lot (1.5 Â 10 8 ) into IBM or PV. The '9 Gy þ PV þ IBM', '8.5 Gy þ PV þ IBM' and '8 Gy þ PV þ IBM' groups showed 100%, 75% (9/12) and 25% (2/8) survival rates, respectively, at 250 days after the transplantation. These results suggest that 'PV þ IBM'-BMT is more effective in inducing the acceptance of allogeneic PIs than IBM-BMT.
Histological findings
To confirm the acceptance of transplanted PIs in normoglycemic-recipient rats, we histologically examined the liver into which PIs had been transplanted via the PV. Sixty days after the transplantation, the livers of PI-accepting rats were stained with H-E (Figure 3a) , anti-insulin Ab (Figure 3b ), anti-glucagon Ab (Figure 3c ) and antisomatostatin Ab (Figure 3d ). The transplanted PIs existed in the portal area, and they produced PI-specific proteins. In contrast, lymphocytes and macrophages had infiltrated the disrupted islets, and the infiltrating mononuclear cells and fibrosis were seen in the livers of PI-rejecting rats with hyperglycemia; no insulin-positive PIs were found in the livers, as described previously. 20 The transplanted PIs in the recipient livers were also examined 180 days after the transplantation (Figure 3e and f) . The grafted islets were reduced to small pieces, which were distributed throughout the liver lobules (Figure 3e) . The islet cells still produced insulin (Figure 3f ). These results suggest that functional PIs existed in the liver of normoglycemic-recipient rats, and that grafted PIs in the livers of hyperglycemic-recipient rats were destroyed by immunological mechanisms.
Flow cytometric analyses of PBMCs
Chimerism in the PB was evaluated by flow cytometric analyses using anti-MHC class I mAbs (anti-RTA l and anti-RTA n ) 60 days after transplantation (Figure 4 ). The PBMCs of the graft-rejecting rats showed only recipient phenotype, whereas the PBMCs of most PI-accepting rats showed donor-type MHC-class I (fully allogeneic chimerism), although some showed mixed chimerism. If the recipient cells were dominant, donor hematopoietic cells finally disappeared, and transplanted PIs were rejected. These results suggest that the existence of donor hematopoietic cells is essential for the successful transplantation of PIs.
Intravenous glucose tolerance tests and serum insulin levels As non-fasting blood glucose levels do not provide an accurate assessment of true regulation of glucose homeostasis, we carried out intravenous glucose tolerance tests were transplanted into vein, BM, PV or PV þ BM, as described in the 'Materials and methods'. Graft rejection was considered to have occurred when posttransplantation non-fasting plasma glucose levels exceeded 300 mg/dl for two consecutive measurements. The control rats, which were transplanted with BMCs and PIs without irradiation, are also shown in each group. The blood glucose in these rats became extremely high within several days after transplantation. Graft survival rates in the experimental groups are shown until 250 days after the transplantation (*Po0.05, **Po0.1).
(IVGTTs) and examined the serum insulin levels to evaluate the function of the grafted PIs 150 days after transplantation. Figure 5a shows the IVGTTs between non-treated normal control F344 rats and the PI-accepting rats with normal glycemia. There was no significant difference in fasting blood glucose levels between the graft-accepting rats and non-treated normal control F344 rats. Fifteen and 30 min after glucose administration, the PI-accepting rats showed slightly higher blood glucose levels than non-treated normal control rats, although there a c e f d b Figure 3 Histological examination of transplanted PIs. Normoglycemic-recipient rats, were killed on day 60 (a, b, c, d) and day180 (e, f) after transplantation, followed by examination of the liver, to which allogeneic PIs had been transplanted via the PV. Histological examination was performed as described in the 'Materials and methods'. The transplanted islet was stained with H-E (a, e), insulin (b, f), glucagon (c) and somatostatin (d).
was no significant difference. Sixty and 120 min after the glucose administration, the blood glucose levels in the PIaccepting rats and non-treated normal control rats had returned to the levels before the glucose administration. Figure 5b shows the serum insulin levels in the PI-accepting rats, the PI-rejecting rats and non-treated normal control F344 rats. The insulin levels in the PI-rejecting rats were significantly lower than those in the non-treated normal rats. The insulin levels in the PI-accepting rats were significantly higher than those in the PI-rejecting rats and were slightly lower than those in non-treated normal rats, although there was no significant difference. These results suggest that glucose homeostasis and insulin levels are maintained by the grafted PIs similar to the original pancreas. The serum insulin levels in the rats treated with 9 Gy irradiation plus IBM injection of only BMCs (without grafting PIs) were similar to those of PI-rejecting rats (data not shown).
MLR
To examine tolerance induction, MLR was carried out 120 days after transplantation ( Figure 6 ). Non-treated normal control F344 and BN rats showed normal proliferative responses to stimulator cells. The T cells of the PI-rejecting rats showed no response to the splenic cells of the recipient F344 rats, whereas they did show responses to both donor and third-party MHC determinants. The T cells of the PIaccepting recipients showed tolerance to not only host-type but also donor-type MHC determinants.
Discussion
In this study, we have shown that simultaneous transplantation of PIs (into the liver) plus BMCs from (PV þ IBM) induces the acceptance of allogeneic PIs, which results in normal glycemia in STZ-induced diabetic rats. Over 1 million people in the USA are estimated to live with T1DM and the incidence of the disease is increasing. 24, 25 Currently, insulin administration is the most common and effective treatment for T1DM. It has been recommended to maintain the blood glucose levels within a tight range to reduce the complications of T1DM. 26 However, good glycemia control is not easily achieved by all patients, and the tight range control of blood glucose Figure 5 IVGTT and serum insulin levels were normalized in PIaccepting rats. IVGTT of islet-transplanted rats in the PI-accepting rats (represented by the '9 Gy þ IBM' group), which show normoglycemia in non-fasting blood, were performed, and compared with those of nontreated rats (a). Serum insulin levels of non-treated normal rats (n ¼ 6), and PI-accepting rats (n ¼ 6) and PI-rejecting rats (n ¼ 6) at 150 days after the transplantation were measured as described in the 'Materials and methods' (*Po0.05). levels increases the risk of hypoglycemia. 5 Therefore, PItransplantaion would physiologically be the most effective treatment, if successfully achieved. In 2000, Shapiro et al. reported that seven consecutive patients achieved euglycemia following islet transplantation using large numbers of donor islets; islets for one patient were obtained from several donors. 27 However, there are still some problems in PI-transplantation: long-term usage of immunosuppressants, rejection of the grafts and destruction of the transplanted PIs by autoimmune mechanisms. The precise etiology of T1DM remains uncertain, but the histological examinations and the experimentation using animal models suggest that some autoimmune mechanisms are involved in the disease. 2, 3, 15, 25 Thus, to suppress rejection and autoimmune reactions, the usage of immunosuppressants is necessary. However, it is well known that the long-term use of immunosuppressants has some harmful effects, such as the development of malignant tumors, infections, the impairment of normal islet functions and/or insulin actions, and renal injury. 28 For patients with diabetes mellitus, renal function is a crucial factor for survival, and calcineurin inhibitors (tacrolimus and cyclosporine) are significantly nephrotoxic. It has been reported that autoimmune diseases can be treated by BMT without immunosuppressants in animal models. 3, [29] [30] [31] [32] [33] Even in humans, the effects of BMT have also been reported. [34] [35] [36] Therefore, the simultaneous transplantation of BMCs plus PIs is an ideal therapy for T1DM, as the rejection of grafted PIs and autoimmune reaction to PIs can be prevented if BMT can be easily performed without the long-term usage of immunosuppressants. For this therapy, a BMT method without long-term usage of immunosuppressants should be established. In this paper, we have shown that both PV-BMT and IBM-BMT are superior to IV-BMT in terms of tolerance induction, and that IBM-BMT is more effective than PV-BMT. Furthermore, we found the combination of PV-BMT plus IBM-BMT ('PV þ IBM'-BMT) to be the most effective method for inducing the acceptance of allogeneic PIs.
Previously, we have reported that there is a correlation between the acceptance of PIs and the existence of donorderived hematopoietic cells in the PB. 20 In this experiment, we have also shown that the existence of donor hematopoietic cells is crucial for the survival of donor PIs. In addition, we have recently shown the same findings in the transplantation of combinations of BMCs and other organs or tissue (such as the skin, leg and lung 18, [37] [38] [39] ) as in PI transplantation. Pham et al. 40 and Foster et al. 41 have also shown the importance of the existence of donor hematopoietic cells for the acceptance of the lung and composite tissue in the transplantation of the combination of BMCs and organs. The absence of a response of T cells in the PI-accepting rats to both recipient and donor MHC determinants in MLR suggests the induction of tolerance in the PI-accepting rats, resulting in long-term acceptance of the grafted PIs without the use of immunosuppressants.
In the present study, we have shown a new effective method of BMT ('PV þ IBM'-BMT) for inducing the acceptance of grafts. Using this method (with a mild conditioning regimen), we have achieved the long-term acceptance of allogeneic PIs in the liver without using immunosuppressants.
